For the quarter ending 2025-09-30, EVOK has $15,649,433 in assets. $12,287,197 in debts. $11,576,010 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 11,576,010 | 12,059,072 | ||
| Accounts receivable, net of allowance for credit losses of 0 | 3,190,486 | 2,905,443 | ||
| Prepaid expenses | 136,295 | 288,572 | ||
| Inventories | 599,908 | 641,872 | ||
| Other current assets | 33,708 | 36,119 | ||
| Total current assets | 15,536,407 | 15,931,078 | ||
| Operating lease right-of-use asset | 106,714 | 122,938 | ||
| Other long-term assets | 6,312 | 6,312 | ||
| Total assets | 15,649,433 | 16,060,328 | ||
| Accounts payable and accrued expenses | 3,916,295 | 3,588,290 | ||
| Accrued compensation | 770,915 | 607,139 | ||
| Operating lease liability | 65,968 | 63,769 | ||
| Note payable | 5,000,000 | 5,000,000 | ||
| Accrued interest payable | 2,487,638 | 2,361,610 | ||
| Total current liabilities | 12,240,816 | 11,620,808 | ||
| Operating lease liability, net of current portion | 46,381 | 65,028 | ||
| Total liabilities | 12,287,197 | 11,685,836 | ||
| Common stock, 0.0001 par value authorized shares - 100,000,000 as of september 30, 2025 and december 31, 2024 issued and outstanding shares - 1,722,409 and 1,486,009 as of september 30, 2025 and december 31, 2024, respectively | 172 | 149 | ||
| Additional paid-in capital | 136,187,058 | 136,043,129 | ||
| Accumulated deficit | -132,824,994 | -131,668,786 | ||
| Total stockholders' equity | 3,362,236 | 4,374,492 | ||
| Total liabilities and stockholders' equity | 15,649,433 | 16,060,328 | ||
Evoke Pharma Inc (EVOK)
Evoke Pharma Inc (EVOK)